Statistics for Fennec Pharmaceuticals (id:5476 FENC)

Valuation metrics

Market cap

110.22M

Enterprise value

101.24M

Trailing P/E (ttm)

60.43

Forward P/E

10.78

PEG ratio

10.78

Price/Sales (ttm)

2.23

Price/Book (mrq)

-28.16

Enterprise Value/Revenue

2.05

Enterprise Value/EBITDA

-8.21

Overview

Shares outstanding

27.43M

Float

14.88M

Shares short

1.78M

% Held by insiders

0.16%

% Held by institutions

0.55%

Average volume (10 days)

143.13K

Average volume (90 days)

Price summary

52-Week low

3.96

52-Week high

11.92

52-Week change

-66.16%

Beta

0.27

50-Day moving average

4.72

200-Day moving average

7.17

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

September 05th, 2014

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-2.30%

Operating margin

-74.59%

Operational effectiveness

Return on assets

2.70%

Return on equity

138.06%

Income statement

Revenue (ttm)

1.81

Revenue per share (ttm)

1.81

Quarterly revenue growth (yoy)

Gross profit (ttm)

19.99M

EBITDA

0.00

Net income to common (ttm)

-1,133,000.00

Diluted EPS (ttm)

-0.04

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

40.32M

Total cash per share (mrq)

1.47

Total debt (mrq)

32.10M

Total Debt/Equity (mrq)

-6.21

Current ratio (mrq)

779.60%

Book value per share (mrq)

-0.19

Cash flow

Cash flow statement

23.59M

Levered free cash flow (LFCF)

-3,402,500.00